# A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects

> **NCT06044233** · PHASE1 · COMPLETED · sponsor: **Zhejiang ACEA Pharmaceutical Co. Ltd.** · enrollment: 32 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** STI-1558

## Key facts

- **NCT ID:** NCT06044233
- **Lead sponsor:** Zhejiang ACEA Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-28
- **Primary completion:** 2023-10-23
- **Final completion:** 2023-11-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06044233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06044233, "A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06044233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*